Testimonials

Background stories of how others approached and experienced their European Horizon funding trajectory.

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Published on | 1 year ago

Programmes

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.

Read the full article for details 
Other available testimonials

Testimonial

AgrifoodTEF - the AI Testing & Experimentation Facility for the agri-food sector

The AgrifoodTEF, funded under the Digital Europe call for a Testing and Experimentation Facility for Agri-Food, is a network of world-class testing and experimentation facilities (TEFs) in the agri-food sector that supports testing state-of-the-art data, AI, and robotics solutions in real-world environments to accelerate their market introduction. ILVO, Flanders Research Institute for Agriculture, Fisheries and Food, the Flemish node of the AgriFoodTEF supports the entire agri-food business, leveraging its infrastructures, experience and vast network established through participation in numerous Digital Europe and Horizon Europe initiatives.